Pressure tracings made from the body of the left ventricle (LV) (A), the body and left ventricular outflow tract (LVOT) (B), and LV body and aorta (C). In B, both catheters record an LV pressure ...
People with symptomatic obstructive hypertrophic cardiomyopathy (HCM) gained functional capacity, and had left ventricular outflow tract (LVOT) gradients reduced, when treated with a cardiac myosin ...
Even though mortality and hospitalization rates have improved, the quality of life for those living with hypertrophic cardiomyopathy (HCM) can be compromised with limiting symptoms such as exertional ...
Background. A 61-year-old man presented with shortness of breath and chest pain on exertion. He had been diagnosed as having hiatus hernia 2 years previously and was taking proton-pump inhibitors as ...
Use of mavacamten, a novel cardiac myosin inhibitor, to treat people with symptomatic obstructive hypertrophic cardiomyopathy (HCM), a condition that results in excess thickening of the heart muscle, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results